-
A Data-Driven Framework for Rare Disease Protocol Design: Integrating Real-World Evidence, Patient Perspectives, and Regulatory Guidance
Sep 9, 2025, 16:22 PM -
Use of Innovative Methods in Long-Term Follow-up Observational Studies: An AI-Enabled Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Association Between Nonvalvular Atrial Fibrillation Type and Therapeutic Failure in Hospitalized Patients With History of Atrial Fibrillation Admitted to a Stepdown Unit
Sep 9, 2025, 16:22 PM -
Public Health Impact of Efluelda, a High-Dose Trivalent Influenza Vaccine (TIV-HD) Compared to Standard-Dose Trivalent Inactivated Vaccines (TIV-SD)
Sep 9, 2025, 16:22 PM -
Enhancing Equity in Cancer Clinical Trials: A Synthesis of Patient-Reported Barriers and Sustainable Solutions
Sep 9, 2025, 16:22 PM -
What Is the Cost of Preventing Tuberculosis a Cost-Effectiveness Analysis of Household Contact Tracing With 3HP Preventive Therapy in High-Burden Areas of Nepal?
Sep 9, 2025, 16:22 PM -
Exploring Value in Healthcare: Patient Satisfaction in Spain Before and After the Pandemic
Sep 9, 2025, 16:22 PM -
Registry Participation in Rare Diseases: Insights from Stakeholders and an Adapted Targeted Literature Review (ATLR)
Sep 9, 2025, 16:22 PM -
HTA Life-Cycle Concepts: The Need for HTA Bodies to Grow Beyond Their Traditional Scope
Sep 9, 2025, 16:22 PM -
Let LAMBA Do the Work: Can We Reduce Reliance on VBA in Health Economic Models?
Sep 9, 2025, 16:22 PM -
Underlying Systemic Motifs That Prevent Diabetes Patients From Seeking and Utilizing Health Services in a Country With a High Prevalence of Diabetes
Sep 9, 2025, 16:22 PM -
Satisfact-Home: Perception of Care Quality and Quality of Life in Patients With Solid Tumors Receiving Immune Checkpoint Inhibitors (ICIs) Therapy From Hospital To Home: A French Multicenter Prospective Observational Study
Sep 9, 2025, 16:22 PM -
Treatment Patterns and Healthcare Resource Utilization Among Patients With Immune Thrombocytopenia: A Real-World Survey
Sep 9, 2025, 16:22 PM -
Bridging the Gap: How Early Access Shapes Pricing and Reimbursed Populations in France
Sep 9, 2025, 16:22 PM -
Economic and Clinical Burden of MACE-Related Rehospitalizations in Patients With Obesity: A Real-World Study Based on Italian Healthcare Data
Sep 9, 2025, 16:22 PM -
Patient and Caregiver Recommendations for Person-Centered Oncology Clinical Trial Design: A Qualitative Study
Sep 9, 2025, 16:22 PM -
Economic Evaluation Of Cefiderocol for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii in Italy Using Real-World Evidence
Sep 9, 2025, 16:22 PM -
Methodological Challenges for the Economic Evaluation of Genomic Newborn Screening: A Scoping Review
Sep 9, 2025, 16:22 PM -
Evaluating Migration Errors in COA: Development and Validation of the IQVIA Migration Error Severity Scale (I-MESS)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among High-Risk Adults in Taiwan
Sep 9, 2025, 16:22 PM
